CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 48 enrolled
Drug / intervention
Ethanol +1 moredrug
Likely dose
Ethanol 0.08 gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04019093
NCT04019093N/ACompleted
CompareCT.gov

Acute Effects of Alcohol Use on Chronic Orofacial Pain

University of Florida·interventional·Posted Jul 15, 2019·Updated Jul 27, 2023

In Brief

A clinical study evaluating Ethanol and Placebo for Temporomandibular Joint Disorders. Completed, enrolled 48 participants across 1 site.

Detailed Summary

Self-medication of pain with alcohol is a common, yet risky, behavior among individuals with chronic orofacial pain. Chronic pain status may affect the degree to which alcohol use relieves pain, but the independent contributions of pain chronification and alcohol-related expectations and conditioning have not been previously studied. This project addresses this gap in knowledge and will inform further research and clinical/translational efforts for reducing risk associated with these behaviors.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTemporomandibular Joint Disorders
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA)

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJul 15, 2019
Enrollment StartNov 5, 2019
Primary CompletionApr 30, 2022
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 7.0 years ago

Interventions

Ethanoldrug

A beverage containing dose of ethanol individually determined to raise a participant's breath alcohol concentration up to approximately 0.08 g/dL.

Placeboother

A beverage that does not meaningfully increase breath alcohol concentration.